A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Edoxaban Impurity 25(1R,2S,4R) Oxalate | CAS 2605225-72-5 - 请求报价

media.product.imagealternatetextformat.details

Edoxaban Impurity 25(1R,2S,4R) Oxalate

SZ目录编号:SZ-E041030
CAS 号
2605225-72-5
分子式
C14H27N3O3 : C2H2O4
分子量
285.4 : 90.0
投资状态
In Stock
Rel. CAS No2089454-69-1 (free base)

化学名称 :

运输温度 :

HSN编码 :

原产国 :

微笑 :

使用说明:

Edoxaban Impurity 25(1R,2S,4R) Oxalate is chemically Tert-butyl ((1S,2R,5R)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate oxalate. Edoxaban Impurity 25(1R,2S,4R) Oxalate is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 25(1R,2S,4R) Oxalate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

应用与法规使用场景

购买 2605225-72-5

采购 2605225-72-5

订购 2605225-72-5

询问 2605225-72-5

price of 2605225-72-5

2605225-72-5 供应商

2605225-72-5 制造商

2605225-72-5 出口商

buy high quality Edoxaban Impurity 25(1R,2S,4R) Oxalate

采购 Edoxaban Impurity 25(1R,2S,4R) Oxalate

Edoxaban Impurity 25(1R,2S,4R) Oxalate 供应商

Edoxaban Impurity 25(1R,2S,4R) Oxalate 制造商

Edoxaban Impurity 25(1R,2S,4R) Oxalate 价格

订购 Edoxaban Impurity 25(1R,2S,4R) Oxalate

询问 Edoxaban Impurity 25(1R,2S,4R) Oxalate

Edoxaban Impurity 25(1R,2S,4R) Oxalate 成本

Edoxaban Impurity 25(1R,2S,4R) Oxalate 供应商

Edoxaban Impurity 25(1R,2S,4R) Oxalate 分销商

Edoxaban Impurity 25(1R,2S,4R) Oxalate 用于方法验证

Edoxaban 对照标准

Edoxaban Impurity 25(1R,2S,4R) Oxalate 用于ANDA申报

Edoxaban Impurity 25(1R,2S,4R) Oxalate 用于强制降解研究

Edoxaban Impurity 25(1R,2S,4R) Oxalate 鉴别标准

Edoxaban Impurity 25(1R,2S,4R) Oxalate 用于DMF申报

ℹ️

免责声明

SynZeal 在本网站上提供的产品信息是根据发布时的现有理解而提供的。客户在实际购买时有责任评估信息的准确性。

SynZeal 将根据产品规格的新发展或新发现更新这些详细信息,恕不另行通知。

,